Activist investor Ancora increased its unsolicited cash offer for H.B. Fuller’s building adhesives segment to $1.4 billion, claiming the sale would accelerate leverage reduction compared to the firm's
chemweek · 2026-09-29 22:59
H.B. Fuller's board rejected Ancora's $1.1–1.2 billion offer for its Building Adhesive Solutions unit, citing undervaluation and strong future growth prospects. The company remains confident in the se
ccin · 2026-08-28 00:00
Activist investor Ancora urges H.B. Fuller to halt its acquisition of Advanced Medical Solutions Group due to leverage concerns. H.B. Fuller defends its M&A strategy and commitment to deleveraging whi
chemweek · 2026-05-27 03:34
ChemBrief